Authors
Latest:
Why Pharma Must Invest in Key Account Management CapabilitiesThe emergence of organized customers demands investment in advanced solutions and next-generation key account management.
Latest:
How to Improve Life Sciences Promotional Review Committees Using Service Operations PrinciplesA deep-dive into how pharma companies can apply service operations principles to achieve a greater level of marketing and promotional review committee satisfaction.
Latest:
Digital-Communication Check: Insights Learned During LockdownA look at the results of recent surveys revealing the impact of the COVID-triggered digital switchover on sales rep interactions and medical conferences.
Latest:
Pharma Forecasting: Key Markets Investors Can’t IgnoreThe importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.
Latest:
Pharmaceutical Executive Daily: Novo Nordisk Resubmits BLA for AwiqliIn today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s resubmission of its BLA for Awiqli, the FDA’s approval of Kedrion’s Qivigy for primary humoral immunodeficiency, and Eli Lilly’s decision to halt development of a muscle-preserving weight-loss therapy.
Latest:
AI-Enabled Benchmarking: Transforming Performance Measurement for Pharma BrandsMarket dynamics boost the need and urgency for more sophisticated benchmarking strategies.
Latest:
To Build AI Maturity, Start With Quick WinsCompanies must determine the right ways to utilize AI.
Latest:
Tuning and Tracking CAR-T Cells for Safer and More Effective Treatment for Solid TumorsWith technological advancements in affinity tuning and real-time tracking of CAR-T cells, the hope is that CAR-T therapy can be effectively applied to treating solid tumors, improve patient outcomes, and avoid the toxicities seen with certain treatments in the clinic.
Latest:
Revenue Optimization: The Money Matters—That Matter MostNavigating technology and regulatory shifts in pharma revenue management.
Latest:
PREP Act Protections for COVID-19 Vaccine LiabilityHow PREP Act protections will apply to potential COVID-19 vaccine-related claims.
Latest:
Enhancing Supply Chain Resilience amid Complexity in Pharma and Medical DevicesThe growing complexity of supply chains necessitates the adoption of collaborative planning processes and capabilities such as S&OP and S&OE.
Latest:
Building the Pharma Talent of Tomorrow from Today’s WorkforceHiring new employees may not be the answer to the war for talent.
Latest:
Abu Dhabi Reinforces Global Leadership in Healthcare Innovation with High-Level US VisitDuring a high-level US visit, the Department of Health—Abu Dhabi signed strategic agreements with Abbott, Boehringer Ingelheim, and Sanofi to boost pharmaceutical manufacturing, expand vaccine development, and advance digital health and clinical research.
Latest:
Future-Ready Leadership: Redefining the Biopharma C-suite for an AI-Driven EraHow will the tasks of C-suite leaders be transformed by intelligent technologies?
Latest:
Fortifying Defenses Pre-Patent CliffIntegrating artificial intelligence and advanced analytics throughout operations offers pharma companies a pathway to offset impending drug patent expirations.
Latest:
Embedded and agile–The next phase of the DCT evolutionEllenor discusses key points from the recent SCOPE presentation.
Latest:
A Clear-Headed Approach to Migraine: Vlad Coric, BiohavenBiohaven CEO Vlad Coric talks to Pharm Exec about NURTEC ODT’s swift and seismic impact on the migraine market.
Latest:
Under PressurePromotional spending is down as companies rationalize and optimize budgets. But in contrast to big changes on the sales side, marketers are still trying to make the old model work
Latest:
Taking It Personally: Building Relationships OnlineTo increase impact and effectiveness, personalized Web sites should be constructed in different ways to interact with multiple audiences.
